OWCP — OWC Pharmaceutical Research Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$1.46m
Annual balance sheet for OWC Pharmaceutical Research, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2014 December 31st | 2015 December 31st | 2016 December 31st | 2017 December 31st | 2018 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 1.47 | 0.357 | 0.472 | 0.971 | 3.46 |
Net Total Receivables | — | 0.012 | — | — | — |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 1.49 | 0.408 | 0.482 | 1.04 | 3.52 |
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.029 | 0.023 | 0.015 | 0.016 | 0.037 |
Total Assets | 1.52 | 0.43 | 0.497 | 1.06 | 3.55 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.06 | 0.108 | 0.146 | 0.27 | 0.438 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 0.06 | 0.108 | 0.396 | 0.27 | 10.8 |
Redeemable Preferred Stock | |||||
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 1.46 | 0.323 | 0.101 | 0.791 | -7.21 |
Total Liabilities & Shareholders' Equity | 1.52 | 0.43 | 0.497 | 1.06 | 3.55 |
Total Common Shares Outstanding |